Novo CEO pressed by Senate to chop prices of weight problems, diabetes medication CEO Lars Fruergaard Jørgensen advised lawmakers the company would look at new talks with insurers with regards to the record selling prices of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. https://troyulbrj.boyblogguide.com/29974481/not-known-factual-statements-about-healthcare-news